Prepare a detailed history and examination of chronic liver ds of 46 year old female preapre a detailed case differential at each step and points in favour and against to rule in rule out differential to arrive at diagnosis use standard books

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Here is the complete, detailed clinical case with step-by-step differential diagnosis at every decision point, compiled from Bailey & Love's Short Practice of Surgery (28th ed.), Harrison's Principles of Internal Medicine (22nd ed., 2025), Goldman-Cecil Medicine, Yamada's Textbook of Gastroenterology, and other standard textbooks.

CLINICAL CASE: Chronic Liver Disease in a 46-Year-Old Female

A Step-by-Step Diagnostic Exercise with Differentials at Every Juncture

PART 1 — HISTORY

Presenting Complaint

Mrs. X, 46-year-old female presents with:

Abdominal distension for 4 months
Generalized weakness and fatigue for 8 months
Yellow discoloration of eyes for 6 weeks
Itching all over the body for 3 months

History of Presenting Complaint (HOPC)

Fatigue and Weakness (8 months):

Insidious onset, gradually progressive
Associated with loss of appetite (anorexia) and weight loss (~6 kg over 6 months)
No fever initially; low-grade fever on and off in recent weeks
Sleep disturbance - sleeps in daytime, awake at night (reversal of sleep cycle - early encephalopathy)

Abdominal Distension (4 months):

Diffuse, progressive
Increased despite dietary changes
Associated with abdominal fullness and discomfort in right hypochondrium
No acute severe pain (rules out acute hepatitis, cholangitis initially)
Swelling of both feet and ankles for 3 months

Jaundice (6 weeks):

Initially noticed as yellow sclerae
Urine became dark (cola-coloured) before jaundice appeared (conjugated hyperbilirubinemia)
Stools: pale/clay-coloured intermittently (suggests cholestasis)
No rigors or acute pain with jaundice (rules against acute cholangitis)

Pruritus (3 months):

Generalized, worse at night
Preceded jaundice by weeks (important - suggests cholestasis/PBC)
Scratch marks noted on arms and trunk
No rash (rules against scabies, eczema as primary cause)

Gastrointestinal:

No haematemesis or melaena (important - no variceal bleed yet, but needs screening)
Occasional nausea, no vomiting
Bowel habits: constipated
No dysphagia

Neurological/Psychiatric:

Forgetfulness, mild confusion at times
Difficulty with arithmetic tasks (West Haven Grade I-II encephalopathy)
No asterixis reported by family (yet to confirm on examination)
No focal deficits

DIFFERENTIAL AT STEP 1 (Presenting Complaint Level)

When a middle-aged woman presents with fatigue + jaundice + abdominal distension + pruritus, the initial broad differential is:

Differential	In Favour	Against
Chronic liver disease / Cirrhosis	All 4 features together, insidious onset, 8-month history	Need to determine aetiology
Obstructive jaundice (extrahepatic)	Pale stools, dark urine, pruritus, jaundice	No acute pain, no rigors, no fever (against stone/cholangitis); prolonged course
Hepatocellular carcinoma	Middle-aged, weight loss, RHC pain, jaundice	Usually on background of cirrhosis; acute presentation less common
Cardiac failure	Oedema, ascites, jaundice	No orthopnoea/PND, no dyspnoea, no palpitations; pruritus unusual in cardiac ascites
Malignancy (GI/ovarian)	Weight loss, ascites, middle-aged female	No GI bleeding, no pelvic symptoms, pruritus not a feature

Clinical priority at this stage: The combination of fatigue + cholestatic features (pruritus preceding jaundice) + ascites in a middle-aged woman strongly narrows to chronic liver disease - the question now is: what type?

Past Medical History

No previous jaundice or hepatitis
No blood transfusions (weakens hepatitis C)
No tattoos or IV drug use (weakens viral hepatitis)
Hypothyroidism - on levothyroxine for 5 years (important - autoimmune association)
Rheumatoid arthritis - diagnosed 7 years ago (autoimmune diathesis - supports AIH/PBC)
Type 2 diabetes mellitus, BMI 29 kg/m² (supports NAFLD/NASH)
No previous surgeries
No history of inflammatory bowel disease (weakens PSC slightly)

Drug History

Levothyroxine 50 mcg once daily
Methotrexate for RA - 12 years (hepatotoxic - causes hepatic fibrosis)
NSAIDs on and off for joint pains
No herbal medicines initially stated (must ask specifically - many cause hepatotoxicity)
No oral contraceptive pill use

DIFFERENTIAL AT STEP 2 (Past Medical / Drug History Level)

Differential	In Favour	Against
Drug-induced liver disease (DILD) - Methotrexate	Long-term use (12 years), known hepatotoxic - causes fibrosis/cirrhosis	Usually insidious; pruritus less prominent; need biopsy to confirm pattern
Autoimmune hepatitis (AIH)	Female, middle-aged, autoimmune comorbidities (thyroid, RA)	Usually hepatitic pattern (elevated transaminases); pruritus less typical early on
Primary Biliary Cholangitis (PBC)	Female (>90% cases), middle-aged, pruritus before jaundice, cholestatic pattern, autoimmune background	Absence of IBD (not against PBC); RA and thyroid disease are recognised associations
NAFLD/NASH cirrhosis	T2DM, BMI 29, female, middle-aged	Cholestatic features (pale stools, severe pruritus) less typical of NAFLD
Wilson's disease	Liver + systemic features	Age 46 less typical (Wilson's usually <40); no neurological features
Primary Sclerosing Cholangitis (PSC)	Cholestatic picture, biliary features	No IBD history (IBD in 70-80% PSC); predominantly male
Viral hepatitis (B or C)	Chronic liver disease features	No transfusions, no IV drug use, no tattoos; pruritus unusual as prominent feature

Key Insight at Step 2: The combination of female + middle-aged + pruritus preceding jaundice + cholestatic features + autoimmune comorbidities makes PBC the leading hypothesis. Drug-induced (methotrexate) liver disease is a serious alternative.

Family History

Mother: died of "liver problem" - details unknown (possible hereditary condition)
No family history of jaundice, Wilson's disease, or iron overload known
No family history of IBD

Social History

Married, 2 children
Non-smoker
Alcohol: Claims to drink "occasionally" - 2 units/week (must quantify - CAGE questionnaire needed)
CAGE Score: 0 (negative for alcohol dependence)
Occupation: school teacher, no occupational exposure to hepatotoxins
Diet: vegetarian

CAGE Questionnaire (Applied)

Question	Response
Cut down?	No
Annoyed by criticism?	No
Guilty?	No
Eye-opener?	No

Score 0/4 - Low suspicion for alcohol-related liver disease

DIFFERENTIAL AT STEP 3 (Social History Level)

Differential	In Favour	Against
Alcoholic Liver Disease	Ascites, jaundice, cirrhosis features	CAGE 0, claims minimal alcohol, no typical AST:ALT >2:1 yet known, vegetarian diet
NAFLD/NASH	T2DM, moderate obesity (BMI 29), sedentary profession	Cholestatic features less typical; pruritus more typical of biliary disease
PBC	All features fit, no alcohol, autoimmune background	Remains leading diagnosis
Hereditary Haemochromatosis	Mother had "liver problem", female	Female usually protected by menstruation until menopause; typically hepatitic not cholestatic

Review of Systems (ROS)

Musculoskeletal: Joint pains (known RA), no new arthritis
Eyes: No visual disturbance (important - Kayser-Fleischer rings in Wilson's cause no early symptoms)
Skin: Pruritus +++, scratch marks, no xanthelasma noted yet
Endocrine: Hypothyroid on treatment, periods now irregular (perimenopausal)
Cardiovascular: No chest pain, no dyspnoea
Respiratory: No cough, no haemoptysis
Neurological: Memory issues, reversal of sleep-wake cycle

PART 2 — PHYSICAL EXAMINATION

General Examination

Appearance: Middle-aged female, slightly confused (mild encephalopathy), icterus present, poorly groomed, wasting of temporal and thenar muscles.

Vitals:

Temperature: 37.4°C (low-grade fever - suggests bacterial infection/SBP or active hepatitis)
Pulse: 96 bpm, regular (hyperdynamic circulation of cirrhosis)
Blood Pressure: 100/68 mmHg (low - vasodilation in portal hypertension)
Respiratory Rate: 18/min
SpO2: 97% on room air

BMI: 29 kg/m² (overweight - consistent with NAFLD risk; however actual lean body mass may be lower due to fluid retention)

DIFFERENTIAL AT STEP 4 (Vitals Level)

Finding	Interpretation
Low BP + high HR	Hyperdynamic circulation of portal hypertension / cirrhosis
Low-grade fever	Active hepatitis, spontaneous bacterial peritonitis (SBP), or biliary infection
Low BP alone	Against cardiac failure (which gives high BP or normal BP early)

Skin and Mucous Membranes

Sign	Present/Absent	Significance
Icterus (scleral)	Present	Bilirubin >2-3 mg/dL
Jaundice	Present (mild-moderate)	Hepatocellular or cholestatic
Spider naevi (>5)	Present (6 - upper torso, face)	Chronic liver disease (>5 is significant)
Palmar erythema	Present (bilateral thenar and hypothenar)	Chronic liver disease, high oestrogen
Leuconychia (white nails)	Present	Hypoalbuminaemia
Clubbing	Absent	(Present in PBC, hepatopulmonary syndrome - its absence weakens PBC slightly)
Dupuytren's contracture	Absent	(More common in alcoholic liver disease)
Parotid enlargement	Absent	(Alcoholic liver disease - now less likely)
Xanthelasma / Xanthomata	Present (small, periorbital)	Cholestatic liver disease, elevated lipids - strongly supports PBC
Excoriation marks	Present (arms, thighs)	Pruritus - cholestasis
Gynecomastia	Not applicable (female)	-
Loss of axillary/pubic hair	Present (reduced)	Hormonal changes in chronic liver disease
Caput medusae	Absent	(Would suggest portal hypertension with re-opened umbilical vein)
Scratch marks	Present	Cholestatic pruritus

DIFFERENTIAL AT STEP 5 (Skin Examination Level)

Finding	Differential Implication
Xanthelasma + pruritus + cholestasis	Strongly favours PBC (classic triad in middle-aged woman)
Spider naevi + palmar erythema	Confirms chronic liver disease - non-specific for aetiology
Leuconychia	Hypoalbuminaemia - chronic hepatocellular disease
Excoriation marks	Prolonged cholestatic pruritus - PBC, PSC, drug-induced cholestasis
No Dupuytren's	Weakens alcoholic liver disease
No parotid enlargement	Weakens alcoholic liver disease

Differential	Points For	Points Against
PBC	Xanthelasma, severe pruritus, cholestatic jaundice, female, middle-aged, autoimmune background	Clubbing absent (though not always present)
Alcoholic CLD	Spider naevi, palmar erythema	No parotid, no Dupuytren's, CAGE 0, no asterixis yet
NAFLD/NASH	BMI 29, DM	Xanthelasma and severe pruritus unusual
Drug-induced (MTX)	Methotrexate use	Cholestatic picture possible but less common with MTX (usually hepatitic/fibrotic)
Autoimmune hepatitis	Female, autoimmune diseases	Cholestatic features and xanthelasma less typical

Head and Neck Examination

Eyes: Scleral icterus. Slit-lamp examination (deferred - to be requested) for Kayser-Fleischer rings (if Wilson's disease suspected)
Parotids: Not enlarged
Lymph nodes: Small right supraclavicular node (0.8 cm) - note and monitor (could be reactive or malignant)
JVP: Not elevated (against cardiac failure)
Tongue: Slightly dry, no flap (hepatic flap/asterixis to be tested separately)

DIFFERENTIAL AT STEP 6 (Head and Neck Level)

Finding	Implication
No elevated JVP	Against congestive cardiac failure as cause of ascites
No Kayser-Fleischer (not yet examined by slit-lamp)	If absent on slit-lamp, strongly against Wilson's disease
Supraclavicular lymphadenopathy	Flag - could be reactive; if malignant, consider HCC with nodal spread

Neurological Examination

Mental status: Mild confusion, slow responses
Orientation: Oriented to person and place, disoriented to time
Asterixis (Hepatic Flap): Present (bilateral, coarse) - elicited by asking patient to dorsiflex hands with arms outstretched for 30 seconds
Speech: Slightly slurred
Cranial nerves: Normal
Motor: No focal weakness
Coordination: Mildly impaired (could be encephalopathy)

West Haven Criteria Grade: Grade II (disorientation to time, asterixis, mild confusion)

DIFFERENTIAL AT STEP 7 (Neurological Level)

Differential	Explanation
Hepatic encephalopathy (HE)	Asterixis, confusion, sleep reversal - classic HE Grade II
Wilson's disease	Can cause neuropsychiatric features + liver disease; however, age 46 less typical (usually <35 years); must do slit-lamp for K-F rings
Wernicke's encephalopathy	Confusion, but no nystagmus, no ophthalmoplegia, no alcohol history
Hypoglycaemia	Liver failure can impair gluconeogenesis; must check blood glucose

Differential	In Favour	Against
Hepatic encephalopathy	Asterixis, Grade II features, known liver disease	-
Wilson's disease	Neurological + hepatic	Age >40, no K-F rings on slit-lamp (if absent = strongly against)
Metabolic (uremia, hypoglycaemia)	Confusion	Check creatinine, blood glucose

Abdominal Examination

Inspection:

Distended abdomen - fullness in flanks
Visible veins on abdomen (flow away from umbilicus - portal hypertension pattern, against IVC obstruction where flow is upward)
No caput medusae
No visible peristalsis
No surgical scars

Palpation:

Liver: Not palpable (shrunken - cirrhosis); dullness in right hypochondrium (suggests liver present but not palpable - consistent with cirrhosis where liver contracts)
Spleen: Palpable, 4 cm below left costal margin - smooth, non-tender
Kidney: Not palpable
No other masses
Murphy's sign: Negative (against acute cholecystitis)
No tenderness in epigastrium (against peptic ulcer)
Fluid thrill: Present
Shifting dullness: Present

Percussion:

Shifting dullness: Confirmed
Liver span: ~9 cm (normal/shrunken - against hepatomegaly, suggests cirrhosis with nodular shrunken liver)

Auscultation:

Bowel sounds: Normal
No bruit over liver (a bruit would suggest AV fistula in HCC)

DIFFERENTIAL AT STEP 8 (Abdominal Examination Level)

Finding	Implication
Shrunken, non-palpable liver	Cirrhosis (end-stage fibrosis - liver contracts in macronodular cirrhosis)
Massive ascites	Portal hypertension; also consider malignancy (but serum-ascites albumin gradient (SAAG) will differentiate)
Splenomegaly	Portal hypertension - consistent with cirrhosis
No hepatomegaly	Against early NAFLD (which gives hepatomegaly), against haemochromatosis (hepatomegaly prominent), against tumour
No palpable gallbladder (Courvoisier's negative)	Against carcinoma of head of pancreas
No tenderness	Against acute cholangitis, against acute hepatitis
Abdominal veins flowing away from umbilicus	Portal hypertension (not IVC obstruction - critical distinction)

Differential	In Favour	Against
Cirrhosis with portal hypertension	Splenomegaly, ascites, shrunken liver, dilated abdominal veins	-
Budd-Chiari syndrome	Ascites, liver disease	No hepatomegaly (Budd-Chiari usually gives large tender liver), abdominal veins flow pattern - confirm on Doppler
Malignant ascites	Weight loss, lymph node	SAAG will show <1.1 (exudative) in malignancy vs >1.1 in portal hypertension
Constrictive pericarditis	Ascites, liver disease	No elevated JVP, no Kussmaul sign, no pericardial knock
IVC obstruction	Ascites, dilated veins	Vein flow is upward in IVC obstruction, here it is away from umbilicus - portal hypertension

Cardiovascular Examination

Apex beat: Normal position
Heart sounds: S1+S2 normal, no murmurs
JVP: Not elevated
No peripheral oedema of cardiac origin (but bilateral pitting oedema present - likely hypoalbuminaemia + portal hypertension)
Hyperdynamic precordium (consistent with hyperdynamic circulation of cirrhosis)

Respiratory Examination

Reduced breath sounds at right base (suggests right-sided pleural effusion - hepatic hydrothorax)
No clubbing (rechecked)
No crepitations

DIFFERENTIAL AT STEP 9 (Multi-System Examination Summary)

At this point, all examination findings synthesize to:

Working Diagnosis: Cirrhosis of the Liver (Stage - Child-Pugh B/C) with complications:

Portal hypertension (splenomegaly, ascites, abdominal venous dilatation)
Hepatic encephalopathy Grade II
Hepatic hydrothorax (right-sided effusion)
Possible spontaneous bacterial peritonitis (low-grade fever)

Aetiology still to confirm - Top differentials:

Rank	Differential Diagnosis	Key Supporting Features
1st	Primary Biliary Cholangitis (PBC)	Female, 46, pruritus preceding jaundice, xanthelasma, cholestatic picture, autoimmune background (thyroid, RA), pale stools
2nd	Drug-induced liver disease (Methotrexate)	12 years MTX, known hepatic fibrosis risk, cirrhosis pattern
3rd	Autoimmune Hepatitis (AIH)	Female, autoimmune disease, middle-aged
4th	NAFLD/NASH Cirrhosis	DM, overweight, no alcohol
5th	Alcoholic Liver Disease	Cirrhosis features (but CAGE 0, no stigmata of ALD)
6th	Wilson's Disease	Neurological features, liver disease (but age 46, K-F rings must be checked)
7th	Hereditary Haemochromatosis	Family history of liver disease (but female, cholestatic features unusual)
8th	Viral Hepatitis B or C Cirrhosis	Cirrhosis features (but no risk factors)

PART 3 — CHILD-PUGH SCORE ASSESSMENT (Bailey & Love's, Table 69.2)

Parameter	Value	Score
Bilirubin	Elevated (estimated ~60 μmol/L)	2
Albumin	Low (estimated ~28 g/L)	2
Ascites	Moderate-large	2
Encephalopathy	Grade II	2
INR	Likely 1.8-2.0	2

Total: ~10 points → Child-Pugh Class C

(Formal score pending bloods; clinical estimate: Class B-C)

PART 4 — INVESTIGATIONS AND DIFFERENTIAL REFINEMENT

Tier 1: Immediate Investigations

Test	Expected Finding	Interpretation
LFTs	ALP and GGT markedly elevated; ALT/AST mildly elevated	Cholestatic pattern - supports PBC, PSC, drug-induced cholestasis
Bilirubin	Elevated, predominantly conjugated	Cholestasis
Albumin	Low (<30 g/L)	Hepatocellular synthetic failure
PT/INR	Prolonged	Impaired clotting factor synthesis
FBC	Low platelets (hypersplenism), anaemia, low WBC	Portal hypertension, hypersplenism
Urea/Creatinine	May be raised (hepatorenal syndrome risk)
Blood glucose	May be low	Impaired gluconeogenesis in cirrhosis
Serum ammonia	Elevated	Hepatic encephalopathy

At this stage: ALP:ALT ratio is the key discriminator:

ALP elevated >> ALT (cholestatic pattern) → PBC, PSC, biliary obstruction, drug cholestasis
ALT elevated >> ALP (hepatocellular pattern) → AIH, viral hepatitis, NAFLD, Wilson's, ALD
ALP from bone vs liver → GGT elevated confirms hepatic source

Tier 2: Aetiological Investigations

Test	Differential It Addresses	Expected in PBC
Anti-mitochondrial antibody (AMA)	PBC - positive in 95% of cases	Positive (titre >1:40)
Anti-nuclear antibody (ANA)	AIH, PBC (ANA-positive PBC variant)	Can be positive in PBC
Anti-smooth muscle antibody (ASMA)	AIH type 1	Negative (supports against AIH)
Anti-LKM1	AIH type 2	Negative
Serum IgM	Markedly elevated in PBC	High IgM - hallmark of PBC
Serum IgG	Markedly elevated in AIH	Normal or mildly elevated
Hepatitis B surface antigen	Viral hepatitis B	Negative
Hepatitis C antibody + RNA PCR	Viral hepatitis C	Negative
Serum ferritin + transferrin saturation	Haemochromatosis	Normal (against HH in female)
Serum ceruloplasmin	Wilson's disease	Normal (against Wilson's at age 46)
24-hour urine copper	Wilson's disease	Normal
Alpha-1-antitrypsin level and phenotype	Alpha-1-AT deficiency
Anti-sp100, anti-gp210	PBC specific antibodies (AMA-negative PBC)	Positive
ASCA, ANCA	IBD-related PSC
p-ANCA	AIH type 1

DIFFERENTIAL AT STEP 10 (Serological Results Level)

Scenario: Results Return as:

AMA positive (titre 1:320)
Anti-sp100 positive
IgM: markedly elevated (580 mg/dL; normal 40-230)
ALP: 420 IU/L (3x ULN)
GGT: 380 IU/L (elevated)
ALT: 65 IU/L (mildly elevated)
ANA: weakly positive 1:80
Hepatitis B, C: Negative
Ceruloplasmin: Normal
Ferritin: Normal
Albumin: 26 g/L
INR: 1.9

Test	Result	Differential Impact
AMA positive (1:320)	Strongly confirms PBC	Sensitivity 95%, Specificity 98% for PBC
IgM markedly elevated	PBC hallmark	AIH elevates IgG, not IgM
Cholestatic LFTs (ALP >> ALT)	PBC, PSC, biliary obstruction	Against AIH (hepatocellular), against NAFLD
Negative HBsAg + HCV	Against viral aetiology
Normal ceruloplasmin	Against Wilson's
Normal ferritin	Against haemochromatosis

Diagnosis at this stage: Primary Biliary Cholangitis (PBC) with Cirrhosis - near certain

But: Methotrexate hepatotoxicity may be a co-existing contributor - cannot be excluded without biopsy.

Tier 3: Imaging

Investigation	Finding Expected	Interpretation
Ultrasound abdomen	Small shrunken nodular liver, splenomegaly, ascites, portal vein diameter >13 mm	Confirms cirrhosis + portal hypertension
Colour Doppler	Portal vein flow direction, varices	Rules out Budd-Chiari (hepatic vein thrombosis)
CT abdomen (triphasic)	Cirrhotic liver, splenomegaly, varices, ascites, no HCC	Staging, rules out HCC
MRCP	Normal intrahepatic and extrahepatic bile ducts	PBC affects intrahepatic small ducts - MRCP normal (PSC shows beading of bile ducts - "string of pearls")
Echocardiogram	Normal cardiac function	Rules out cardiac cause of ascites/jaundice

MRCP is critical to differentiate PBC from PSC:

PBC: MRCP normal (small duct disease)
PSC: MRCP shows multifocal strictures and dilations ("beading") of bile ducts

Tier 4: Liver Biopsy

Although not always required when AMA is strongly positive with cholestatic picture, biopsy is indicated here for:

Staging PBC (Ludwig staging)
Assessing methotrexate-related damage (concurrent hepatotoxicity)
Ruling out AIH-PBC overlap syndrome (occurs in 10% of PBC patients)

Ludwig Staging of PBC:

Stage	Histology
I	Portal tract inflammation, florid duct lesion
II	Periportal inflammation, ductular proliferation
III	Bridging fibrosis
IV	Cirrhosis

Expected finding: Stage IV PBC (cirrhosis) + possibly methotrexate-related stellate cell activation/fibrosis as co-contributor

Ascitic Fluid Analysis (Diagnostic Paracentesis - Mandatory in New Ascites)

Parameter	Expected Result	Interpretation
SAAG (Serum-Ascites Albumin Gradient)	>1.1 g/dL	Portal hypertension - confirms cirrhotic ascites (not malignant)
Ascitic protein	>2.5 g/dL	Risk of SBP
Ascitic WBC / neutrophil count	>250 neutrophils/mm³	Spontaneous Bacterial Peritonitis (SBP) - explains low-grade fever
Culture and sensitivity	Gram-negative organisms (E. coli)	SBP aetiology
Cytology	No malignant cells	Against malignant ascites
LDH/glucose	Normal range	Against TB peritonitis

DIFFERENTIAL AT STEP 11 (Ascitic Fluid Level)

SAAG	Diagnosis
>1.1 g/dL	Portal hypertension (cirrhosis, cardiac failure, Budd-Chiari)
<1.1 g/dL	Malignancy, TB, pancreatitis, nephrotic syndrome

The SAAG >1.1 with positive AMA + cholestatic picture firmly establishes PBC with portal hypertension and SBP as the acute-on-chronic presentation.

PART 5 — FINAL DIFFERENTIAL RANKING AND RULE IN / RULE OUT TABLE

Diagnosis	In Favour	Against	Verdict
Primary Biliary Cholangitis (PBC)	Female, 46, pruritus before jaundice, xanthelasma, cholestatic LFTs (ALP >>), IgM elevated, AMA positive (1:320), autoimmune comorbidities, MRCP normal	Clubbing absent (minor)	CONFIRMED - Primary Diagnosis
Methotrexate Hepatotoxicity (Co-existing)	12 years MTX use, hepatic fibrosis known side effect	Cannot be the only cause - cholestatic pattern and AMA positive are specific to PBC	Likely Co-contributor
Autoimmune Hepatitis	Female, autoimmune comorbidities	IgG not markedly elevated, AMA positive (not AIH), hepatocellular not cholestatic pattern	Ruled Out (unless AIH-PBC overlap on biopsy)
NAFLD/NASH Cirrhosis	BMI 29, T2DM	Cholestatic pattern, pruritus, AMA positive, xanthelasma	Ruled Out as primary; may co-exist
Primary Sclerosing Cholangitis	Cholestatic picture	No IBD, female (PSC predominately male), MRCP normal (not beaded ducts), AMA positive	Ruled Out
Alcoholic Liver Disease	Cirrhosis features	CAGE 0, no parotid, no Dupuytren's, no AST:ALT >2:1, AMA positive	Ruled Out
Wilson's Disease	Neurological + liver	Age 46 (unusual), ceruloplasmin normal, AMA positive	Ruled Out
Hereditary Haemochromatosis	Family history	Female, cholestatic features, normal ferritin, AMA positive	Ruled Out
Viral Hepatitis B/C Cirrhosis	Cirrhosis features	No risk factors, HBsAg negative, HCV antibody negative	Ruled Out
Budd-Chiari Syndrome	Ascites, liver disease	Doppler normal hepatic veins, AMA positive, no hepatomegaly, abdominal vein pattern	Ruled Out
Malignancy	Weight loss, lymph node	SAAG >1.1, AMA positive, no mass on CT, cytology negative	Ruled Out

PART 6 — FINAL DIAGNOSIS

Primary Diagnosis:

Primary Biliary Cholangitis (PBC), Ludwig Stage IV (Cirrhosis) Complicated by: Portal hypertension, Ascites with Spontaneous Bacterial Peritonitis, Hepatic Encephalopathy Grade II, Hepatic Hydrothorax

Contributing/Co-existing:

Methotrexate-induced hepatic fibrosis (probable accelerator of disease)

Child-Pugh Score: Class C (10 points) MELD Score to be calculated (requires creatinine, INR, bilirubin)

PART 7 — MANAGEMENT OUTLINE (Based on Diagnosis)

Issue	Management
PBC	Ursodeoxycholic acid (UDCA) 13-15 mg/kg/day - first-line; Obeticholic acid for incomplete UDCA response
SBP	IV cefotaxime 2g 8-hourly; secondary prophylaxis with norfloxacin
Ascites	Sodium restriction + spironolactone ± furosemide; large-volume paracentesis for tense ascites
Hepatic encephalopathy	Lactulose titrated to 2-3 soft stools/day; rifaximin 550 mg BD; identify precipitant (SBP)
Pruritus	Cholestyramine; rifampicin; naltrexone; UDCA
Methotrexate	Discontinue immediately
Varices	Upper GI endoscopy for variceal screening; beta-blocker (propranolol/carvedilol) if varices present
HCC surveillance	6-monthly AFP + liver ultrasound
Liver transplantation	Evaluate - PBC with cirrhosis and Child-Pugh C is a transplant indication; MELD >15 should be listed
Osteoporosis	Calcium + Vitamin D + DEXA scan (PBC causes metabolic bone disease)
Fat-soluble vitamins	Supplement A, D, E, K

SUMMARY: Diagnostic Reasoning Pathway

Female, 46 → Fatigue + Pruritus BEFORE jaundice + Xanthelasma + Pale stools
          ↓
Cholestatic liver disease (ALP >> ALT, GGT elevated, IgM high)
          ↓
Autoimmune background (thyroid, RA) + No alcohol + No viral risk factors
          ↓
AMA positive (1:320) + Anti-sp100 positive + IgM markedly elevated
          ↓
MRCP normal (rules out PSC - which shows ductal beading)
          ↓
Biopsy: Stage IV PBC with bridging fibrosis/cirrhosis
          ↓
FINAL DIAGNOSIS: PBC Cirrhosis + SBP + HE Grade II

References:

Bailey and Love's Short Practice of Surgery, 28th Edition - Chapter 69 (Liver, Biliary Tract and Pancreas)
Harrison's Principles of Internal Medicine, 22nd Edition (2025) - Chapters on Chronic Liver Disease, PBC, and Iron Overload
Goldman-Cecil Medicine - Chapters on Cryptogenic and Autoimmune Liver Disease
Yamada's Textbook of Gastroenterology, 7th Edition - Differential Diagnosis of Cholestatic Liver Disease
Frameworks for Internal Medicine - Hepatocellular and Cholestatic Liver Injury pattern recognition

In the same format generate case presentation on WILSON DISEASE

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

CLINICAL CASE: WILSON DISEASE (Hepatolenticular Degeneration)

A Step-by-Step Diagnostic Exercise with Differentials at Every Decision Point

CASE INTRODUCTION

Patient: Master Arjun S., 19-year-old male student Referred by: Psychiatry team (initially admitted for "behavioural disturbance") Setting: Tertiary hospital, Medicine ward

Wilson disease is an autosomal recessive disorder of copper transport due to mutations in both alleles of the ATP7B gene on chromosome 13. The gene encodes a copper-transporting ATPase expressed primarily in hepatocytes, whose major function is excretion of hepatic copper into the biliary tract. With impaired excretion, copper accumulates first in the liver, then in the brain (basal ganglia), eyes (corneal Descemet membrane), kidneys, bones, and red blood cells.

Goldman-Cecil Medicine, Chapter 395

PART 1 — HISTORY

Presenting Complaints

Behavioural change and personality disturbance - 10 months
Trembling of both hands - 6 months
Slurred speech and drooling - 4 months
Yellow discoloration of eyes - 3 months
Abdominal swelling - 2 months
Decline in academic performance - 12 months (first symptom - retrospectively identified)

History of Presenting Complaints (HOPC)

Neurological/Psychiatric Onset (12-10 months ago):

First symptom was decline in academic performance - from a top student to failing exams over one year
Parents initially attributed this to "exam stress"
Followed by personality changes: increasing irritability, anger outbursts, poor self-control, social withdrawal
Mood disorder: depression diagnosed and treated by a psychiatrist with antidepressants - no improvement
Behavioural disinhibition: inappropriate laughing and crying (emotional lability)
No hallucinations; no formal thought disorder initially

Motor Symptoms (6 months ago):

Tremor: bilateral, began in dominant right hand, coarse, present at rest and with posture; also wing-beating component (arms abducted, elbows flexed - classic)
Worsened with purposeful movement (kinetic component)
Dystonia: abnormal posturing of right arm noticed during writing
Dysarthria: speech became progressively slurred, difficult to understand
Dysgraphia: handwriting became "illegible" over 6 months
Drooling: unable to control saliva, parents noted open-mouth posture
Gait disturbance: unsteady, wide-based
Dysphagia: difficulty swallowing solids - started 2 months ago

Hepatic Symptoms (3-2 months ago):

Jaundice: yellow discoloration of eyes appeared 3 months ago
Dark urine (cola-coloured), pale stools intermittently
Abdominal distension: 2 months, progressive
Anorexia and weight loss (~8 kg in 6 months)
No haematemesis or melaena
Mild right upper quadrant discomfort

Note on Symptom Sequence: The sequence - psychiatric → neurological → hepatic is highly characteristic of Wilson disease. About one-third present with each system, but in many patients, careful history reveals psychiatric features pre-dating motor signs. - Bradley and Daroff's Neurology in Clinical Practice

DIFFERENTIAL AT STEP 1 (Presenting Complaint Level)

A 19-year-old male with the triad of psychiatric symptoms + movement disorder + liver disease must have Wilson disease excluded urgently.

Differential	In Favour	Against
Wilson disease	Young age, all three systems involved (psychiatric + neurological + hepatic), tremor, dysarthria, drooling, jaundice	-
Autoimmune hepatitis (AIH)	Young, jaundice, liver disease	Does not explain movement disorder, tremor, psychiatric features
Viral hepatitis (B or C) with encephalopathy	Jaundice, abdominal distension, altered behaviour	HE does not produce tremor/dystonia; no risk factors mentioned; chronic course unusual for acute viral hepatitis
Parkinson's disease	Tremor, rigidity, bradykinesia	Age 19 is extremely unusual; no liver disease in PD; no psychiatric features of this type
Juvenile Huntington's disease	Chorea, psychiatric features, young	Autosomal dominant (family history needed), does not cause liver disease
Schizophrenia	Bizarre behaviour, adolescent onset	No movement disorder, no liver disease in schizophrenia
Substance abuse	Adolescent, behavioural change	Would not produce extrapyramidal syndrome + liver disease together
Hepatic encephalopathy (other cause)	Altered behaviour, jaundice, ascites	Acute HE does not produce the chronic progressive movement disorder seen here

Key Clinical Insight at Step 1: "Wilson disease should be considered and formally excluded in all young adults with new-onset psychiatric symptoms, especially if liver function tests are abnormal or a family history of Wilson disease is noted." - Goldman-Cecil Medicine

Past Medical History

Diagnosed with depression 8 months ago - on escitalopram (no response, slight worsening)
No previous jaundice
No previous liver disease
No blood transfusions
No known haematological disease
Hospitalised once 3 years ago for "hepatitis" - investigation incomplete; recovered spontaneously (this may represent an earlier hepatic presentation of Wilson disease)

DIFFERENTIAL AT STEP 2 (Past Medical History Level)

Finding	Implication
Prior "hepatitis" episode 3 years ago	May have been Wilson's hepatitis - prior copper deposition episode
Depression not responding to antidepressants	Organic psychiatric disease - Wilson's disease must be excluded before labelling as primary psychiatric disorder
Worsening on SSRI/antidepressants	Some Wilson's patients have increased sensitivity to psychotropic drugs

Family History

Elder sister (24 years): "some liver problem" - details unknown, was told "fatty liver" (undiagnosed Wilson disease in sibling is possible)
Parents: consanguineous marriage (first cousins) - critically important for autosomal recessive disease
Father: no known illness
Mother: no known illness
No known neurological disease in family

DIFFERENTIAL AT STEP 3 (Family History Level)

Finding	Implication
Consanguinity	Markedly increases probability of autosomal recessive condition - Wilson disease (ATP7B mutation), haemochromatosis, alpha-1-AT deficiency, glycogen storage disease
Sibling with liver disease	Same autosomal recessive mutation in family - Wilson disease highly probable; sibling should be screened
No dominant inheritance pattern	Against Huntington's disease, familial PD, hereditary spastic paraplegia

"For special populations in which consanguinity is common, the incidence of Wilson disease is higher." - Goldman-Cecil Medicine

At this point, consanguinity + liver + neuro + psychiatric in a 19-year-old = Wilson disease until proven otherwise.

Drug and Dietary History

Escitalopram 10 mg once daily (8 months - no benefit)
No herbal medicines
No IV drug use
No alcohol (confirmed by family)
Diet: mixed diet; consumes shellfish and liver frequently (high copper-containing foods - important)
No hepatotoxic drugs

Social History

Student, final year of school
Non-smoker, non-alcoholic
No tattoos, no high-risk sexual behaviour
No travel history
Lives with family in a joint household (supports consanguinity context)
Academic decline noticed by teachers 12 months ago

Review of Systems

Musculoskeletal: Joint pain in both knees and wrists for 6 months (copper deposition in joints/periarticular tissues)
Renal: Frothy urine (proteinuria) - suggests renal tubular involvement (Fanconi syndrome)
Haematological: Occasional episodes of pallor and mild icterus without liver symptoms in past (suggests intermittent haemolytic episodes)
Endocrine: No amenorrhoea (male); no delayed puberty noted
Ophthalmological: No visual complaints (KF rings do not impair vision)
Dermatological: No specific skin changes

PART 2 — PHYSICAL EXAMINATION

General Examination

Appearance: Young male, 19 years, looks slightly younger than stated age (chronic disease). Icteric, appears anxious. Fixed vacant stare with a characteristic "sardonic smile" (risus sardonicus). Drooling from corners of mouth. Dishevelled, unkempt appearance.

Vitals:

Temperature: 37.2°C
Pulse: 88 bpm, regular
Blood Pressure: 108/72 mmHg
Respiratory Rate: 16/min
SpO2: 98%

Anthropometry: BMI 18.5 kg/m² (thin, weight loss)

DIFFERENTIAL AT STEP 4 (First Impression / Vitals Level)

Finding	Implication
Risus sardonicus (fixed sardonic smile)	Classic Wilson disease feature - dystonia of facial muscles
Drooling	Dystonia of bulbar/oropharyngeal muscles - Wilson disease
Icteric	Hepatic involvement - jaundice from liver disease ± haemolysis
Low BMI, weight loss	Chronic disease, malnutrition, hypermetabolism of liver disease
Normal pulse and BP	Against decompensated cardiac disease

Ophthalmological Examination (Most Crucial Examination in Wilson Disease)

Naked Eye:

Scleral icterus present
No obvious corneal discoloration on naked eye inspection

Slit-Lamp Examination (Performed by Ophthalmologist - Mandatory):

Kayser-Fleischer (KF) rings: PRESENT bilaterally - golden-brown granular deposits in the periphery of the cornea in the Descemet membrane
Rings are complete (circumferential) - first appearing superiorly, then inferiorly, then completing the circle
Sunflower cataract: Present (copper deposits in lens in a petal-like pattern - does not impair vision)

DIFFERENTIAL AT STEP 5 (Ophthalmological Examination Level - MOST IMPORTANT STEP)

Finding	Diagnostic Weight
KF rings present on slit-lamp	Present in 98% of Wilson disease patients with neurological disease
KF rings present	KF rings are present in 80% of ALL Wilson disease cases
KF rings absent	Would be present in only ~50-65% of those with purely hepatic presentation - absence does not exclude Wilson disease
Sunflower cataract	Specific to Wilson disease (copper in lens)

Other conditions producing KF-like corneal changes (extremely rare):

Primary biliary cholangitis (cholestatic liver disease with elevated copper)
Neonatal cholestasis (prolonged)

Differential	KF Rings	Comment
Wilson disease	Present in 98% neurological cases	CONFIRMED by slit-lamp
Parkinson's disease	Absent	KF rings essentially rule in Wilson disease
Huntington's disease	Absent
AIH / viral hepatitis	Absent
Primary biliary cholangitis	Rarely, in advanced disease	But PBC presents in middle-aged women, not 19-year-old males

KF rings + neurological signs = Wilson disease diagnosis until proven otherwise

Neurological Examination

Higher Mental Function:

Oriented to person and place; disoriented to time
Attention and concentration: impaired
Memory: short-term impaired
Abstract thinking: reduced
Frontosubcortical pattern of cognitive deficit (not cortical dementia)

Speech:

Dysarthria: severe, scanning/slurred quality
Hypophonia (soft voice)
No aphasia (comprehension intact)

Cranial Nerves:

III, IV, VI: Full eye movements, no nystagmus
V: Intact sensation
VII: Mild lower motor neurone pattern facial weakness (dystonic component)
IX, X: Gag reflex present but sluggish; dysphagia confirmed
XII: Tongue deviation with mild dystonic posturing

Motor Examination:

Tone: Increased (lead-pipe rigidity) in all four limbs - predominantly upper > lower
Tremor: Present at rest, postural, and kinetic; wing-beating tremor elicited (arms abducted, elbows bent) - coarse, high-amplitude
Dystonia: Focal dystonia of right arm; facial grimacing; writer's cramp
Bradykinesia: Reduced arm swing bilaterally on walking
Cerebellar signs: Dysmetria on finger-nose test, dysdiadochokinesis - mild

Gait:

Wide-based, shuffling, with intermittent festination
Positive pull test (retropulsion)

Reflexes:

Brisk in upper limbs; normal in lower limbs
No pyramidal signs (plantars flexor bilaterally) - against cortical/UMN lesion

Sensory:

Intact to all modalities

DIFFERENTIAL AT STEP 6 (Neurological Examination Level)

Neurological Finding	Differential Implications
Wing-beating tremor	Classic Wilson disease; also (rare) in Huntington's, essential tremor
Dystonia + rigidity + tremor (mixed)	Wilson disease; also Huntington's, Wilson's mimics
Dysarthria + drooling + dysphagia	Bulbar involvement - Wilson disease, MND (too young), syringobulbia
Cerebellar signs	Wilson disease (copper in cerebellum); spinocerebellar ataxia
KF rings + extrapyramidal syndrome	Pathognomonic combination for Wilson disease
Cognitive: frontosubcortical	Wilson disease (basal ganglia + thalamus + frontal connections)

Differential	In Favour	Against
Wilson disease	KF rings, wing-beating tremor, dystonia, mixed extrapyramidal + cerebellar + psychiatric, young, consanguinity, liver disease	-
Parkinson's disease	Tremor, rigidity, bradykinesia	Age 19 (very unusual), KF rings present (not PD), cerebellar signs, liver disease
Juvenile Huntington's disease	Chorea, psychiatric, young	Autosomal dominant (consanguinity fits AR not AD), no liver disease, no KF rings
Multiple system atrophy	Extrapyramidal + cerebellar + autonomic	Age >50 typical; no liver disease; no KF rings
Spinocerebellar ataxia	Cerebellar signs, young	Predominantly cerebellar; no extrapyramidal signs, no liver disease, no KF rings
Drug-induced movement disorder	On escitalopram (rare)	Escitalopram rarely causes EPS; not sufficient to explain full picture
Sydenham's chorea	Young, movement disorder	No preceding rheumatic fever, no chorea (predominantly), no liver disease

Abdominal Examination

Inspection:

Distended abdomen - flanks full
Visible abdominal veins (away from umbilicus - portal pattern)
No caput medusae
No surgical scars
No prominent peristalsis

Palpation:

Liver: Palpable 3 cm below the right costal margin, firm, nodular surface (cirrhosis) - hepatomegaly present (Wilson disease in early/active stage: hepatomegaly; later: shrunken cirrhotic liver)
Spleen: Palpable 2 cm below left costal margin (splenomegaly - portal hypertension)
Fluid thrill: Present
Shifting dullness: Present
No tenderness; no rebound; no guarding
Murphy's sign: Negative

Percussion:

Shifting dullness confirmed
Liver span: 14 cm (hepatomegaly)

Auscultation:

Normal bowel sounds, no liver bruit

DIFFERENTIAL AT STEP 7 (Abdominal Examination Level)

Finding	Implication
Hepatomegaly (palpable, nodular, firm)	Active liver disease with fibrosis; consistent with Wilson disease hepatitis/early cirrhosis
Splenomegaly	Portal hypertension
Ascites	Portal hypertension / hypoalbuminaemia
Liver palpable (not shrunken)	Earlier stage of cirrhosis than end-stage PBC; Wilson disease can present with palpable liver

Differential	In Favour	Against
Wilson disease	Hepatomegaly + portal hypertension + ascites in young, KF rings, movement disorder	-
Autoimmune hepatitis	Female-predominant but can occur in young males; hepatomegaly, jaundice	No extrapyramidal signs, no KF rings
Chronic Hepatitis B	Hepatomegaly, portal HTN, young patient in endemic area	No viral risk factors; no extrapyramidal signs
Haemochromatosis	Young, liver disease	Hepatomegaly; but typically no neurological signs, no KF rings; iron overload not copper
Glycogen storage disease	Young, hepatomegaly	No portal hypertension typically; no neurological pattern of Wilson disease

Skin Examination

Sign	Present/Absent	Significance
Jaundice	Present	Hepatic dysfunction ± haemolysis
Pallor	Mild	Haemolytic anaemia (Coombs-negative)
Spider naevi (3)	Present	Chronic liver disease
Palmar erythema	Present	Chronic liver disease
Leuconychia	Present	Hypoalbuminaemia
Azure lunulae (blue lunulae)	Present (subtle)	Copper deposition in nail beds - specific to Wilson disease
Hyperpigmentation (slate-grey)	Mild, lower legs	Copper deposition in skin (Wilson disease feature)
No xanthelasma	Absent	Against PBC (cholestatic)
No Dupuytren's	Absent	Against alcoholic liver disease

DIFFERENTIAL AT STEP 8 (Skin + Full Examination Integration)

Finding	Differential Impact
Azure lunulae (blue nail lunulae)	Pathognomonic of copper deposition - Wilson disease
No xanthelasma	Against PBC
Coombs-negative haemolytic anaemia (pallor + jaundice)	"Acute Coombs-negative intravascular haemolysis" - classic Wilsonian hepatic presentation (Sleisenger & Fordtran)
Spider naevi + palmar erythema	Chronic liver disease - non-specific

Cardiovascular and Respiratory Examination

JVP: Not elevated
Heart sounds: Normal
No murmurs
Reduced breath sounds at right base (hepatic hydrothorax)
No cardiac failure features

PART 3 — SYNTHESIS AT END OF CLINICAL EXAMINATION

Clinical Diagnosis Framework

The triad of Wilson disease (Goldman-Cecil Medicine):

Liver disease (hepatomegaly, portal hypertension, cirrhosis, jaundice) ✓
Neuropsychiatric disease (psychiatric → extrapyramidal → cerebellar) ✓
Kayser-Fleischer rings on slit-lamp ✓

Additional supporting features found:

Consanguinity ✓
Sibling with liver disease ✓
Age 19 (peak presentation) ✓
Azure lunulae ✓
Sunflower cataract ✓
Coombs-negative haemolysis suggested ✓
Prior undiagnosed "hepatitis" episode ✓
High-copper diet (shellfish, liver) ✓
Frothy urine (renal Fanconi syndrome) ✓

Complete Differential Diagnosis after Full Clinical Examination

Rank	Diagnosis	Key Supporting Features
1st	Wilson disease	KF rings + wing-beating tremor + dystonia + psychiatric + liver disease + consanguinity + young age + Azure lunulae
2nd	Autoimmune Hepatitis	Young patient, jaundice, hepatomegaly, no other cause - but extrapyramidal signs and KF rings not explained
3rd	Chronic Hepatitis B	Liver disease, young, ascites - but no viral risk factors, no extrapyramidal signs
4th	Juvenile Huntington's disease	Psychiatric + movement disorder - but autosomal dominant (not AR), no liver disease, no KF rings
5th	Parkinson's disease	Tremor + rigidity - but age 19 extremely unusual, KF rings present, liver disease
6th	Drug-induced movement disorder	On escitalopram - but insufficient to explain full picture
7th	Spinocerebellar ataxia	Cerebellar signs - but predominantly cerebellar, no liver, no KF rings

PART 4 — INVESTIGATIONS WITH DIFFERENTIAL AT EACH STEP

Tier 1: Bedside and Emergency Investigations

Test	Expected Finding	Interpretation
Blood glucose	May be low	Impaired hepatic gluconeogenesis
Urine dipstick	Protein +++ , glucose + (without diabetes)	Renal tubular dysfunction (Fanconi syndrome) - copper in proximal tubule
Urine microscopy	Casts, RBC	Renal involvement
PT/INR	Prolonged	Hepatic synthetic failure

DIFFERENTIAL AT URINE FINDINGS:

Glycosuria without hyperglycaemia + proteinuria + aminoaciduria = Renal Fanconi Syndrome
In a young patient with liver disease and movement disorder: Fanconi syndrome = Wilson disease (copper deposition in proximal tubule)

Tier 2: Blood Tests

Liver Panel:

Test	Expected in Wilson Disease	Interpretation
Bilirubin	Elevated (total + unconjugated component high)	Hepatocellular dysfunction + haemolysis
AST	Elevated (2-5x ULN)	Hepatocellular injury
ALT	Elevated (1-3x ULN)	Hepatocellular injury
AST:ALT ratio	>2.2	Wilsonian ALF: ALP/bilirubin <4 + AST/ALT >2.2 (diagnostic of Wilsonian ALF)
ALP	Disproportionately LOW	Paradoxically low/normal ALP is characteristic of Wilson disease - copper inhibits alkaline phosphatase synthesis
Albumin	Low (27 g/L)	Synthetic failure
GGT	Mildly elevated	Hepatocellular disease

Key Diagnostic Ratio:

"Ratios of serum alkaline phosphatase to total bilirubin below 4 and AST to ALT above 2.2 accurately distinguish Wilson disease from other causes of ALF." - Sleisenger & Fordtran's Gastrointestinal and Liver Disease

Haematological Panel:

Test	Expected	Interpretation
Haemoglobin	Low (9.5 g/dL)	Haemolytic anaemia
Direct Coombs test (DAT)	NEGATIVE	Coombs-NEGATIVE haemolytic anaemia - hallmark of Wilson disease; distinguishes from autoimmune haemolysis
Blood smear	Fragmented RBCs (schistocytes), spherocytes	Intravascular haemolysis
Reticulocyte count	Elevated	Compensatory reticulocytosis
Platelet count	Low (hypersplenism)	Portal hypertension
WBC	Low-normal	Hypersplenism
LDH	Elevated	Haemolysis + hepatocellular necrosis

DIFFERENTIAL AT STEP - HAEMATOLOGY:

Haemolytic Anaemia Type	DAT	Disease
Wilson disease	Negative	Copper-induced RBC membrane damage
Autoimmune haemolytic anaemia	Positive	Autoimmune disorder
Microangiopathic haemolytic anaemia (HUS/TTP)	Negative	But thrombocytopenia severe, fragmented cells prominent
Paroxysmal nocturnal haemoglobinuria	Negative	CD55/CD59 absent on flow cytometry

Copper Studies (The Definitive Tests):

Test	Normal	Wilson Disease	Interpretation
Serum ceruloplasmin	0.20-0.60 g/L	< 0.10 g/L (markedly low)	Low in 96% of cases; also low in malnutrition, nephrotic syndrome, end-stage liver disease
24-hour urine copper	< 40 μg/day	> 100 μg/day (often > 200)	Markedly elevated - copper excreted in urine due to overflow from liver
Serum copper	70-140 μg/dL	Low (paradoxically)	Total serum copper low because ceruloplasmin-bound copper is low; free (non-ceruloplasmin-bound) copper is elevated
Free serum copper (calculated)	< 15 μg/dL	Elevated (>25 μg/dL)	= Total serum copper - (3.15 × ceruloplasmin)

DIFFERENTIAL AT STEP - COPPER STUDIES:

Condition	Ceruloplasmin	Urine Copper	Comment
Wilson disease	Low	High	Pathognomonic combination
Menkes disease	Low	Low/normal	X-linked (male), neonatal onset
Nephrotic syndrome	Low	-	No liver/neuro disease
Protein malnutrition	Low	Normal	No copper deposition signs
End-stage liver disease (any cause)	Low	Variable	But ceruloplasmin not as profoundly low; no KF rings
PBC (advanced)	Elevated	Elevated	KF rings possible but rare; middle-aged female

Note: "A few affected patients have normal ceruloplasmin. Therefore, if there is high suspicion for Wilson disease, the 24-h urine copper excretion, slit-lamp examination, and liver biopsy should be performed despite a low-normal ceruloplasmin." - Yamada's Textbook of Gastroenterology

Tier 3: Liver Biopsy

Indications: Biochemical results equivocal, staging of disease, ruling out concurrent AIH, histochemical copper quantification.

Finding	Expected in Wilson Disease
Hepatic copper quantification	> 250 μg/g dry weight (normal: 20-50 μg/g); >5× ULN = 2 points on Leipzig score
Rhodanine/Orcein stain	Positive - copper deposits in hepatocytes
Histology	Steatosis + focal necrosis → Chronic hepatitis pattern → Cirrhosis (Macronodular)
Mallory hyaline bodies	Present (steatohepatitis pattern)
Ballooned hepatocytes	Present

Tier 4: Neuroimaging

MRI Brain (T2-weighted):

Region	Finding in Wilson Disease	Significance
Putamen	Hypointense (copper deposition) on T1; hyperintense on T2	Most common finding
Midbrain tegmentum	Hyperintense (sparing red nuclei)
"Face of the giant panda" sign	Hyperintense midbrain tegmentum + hypointense red nuclei + normal superior colliculi on T2	Pathognomonic MRI sign of Wilson disease
Globus pallidus, thalamus, cerebellum	Variable signal abnormalities	Widespread basal ganglia involvement
Cerebral cortex	Atrophy (if advanced)
White matter	Hyperintense lesions

DIFFERENTIAL AT MRI STEP:

MRI Pattern	Differential
"Face of the giant panda" sign	Pathognomonic of Wilson disease
Bilateral basal ganglia hyperdensity	Bilateral striatal necrosis (NBIA), Leigh disease
Bilateral putaminal T2 hyperintensity	Wilson disease, MSA, Japanese encephalitis
No lesions	Does not exclude Wilson disease (early cases)

Tier 5: Genetic Testing

Test	Finding	Significance
ATP7B gene mutation analysis	Two pathogenic mutations identified	Confirms Wilson disease; 4 points on Leipzig score
Genotyping siblings	Same mutations	Identifies presymptomatic siblings for early treatment

"Genotyping of ATP7B may be useful if diagnosis cannot be definitively established using biochemical and clinical criteria." - Yamada's Textbook of Gastroenterology

PART 5 — THE LEIPZIG SCORING SYSTEM (Yamada's; Sleisenger & Fordtran)

This validated scoring system integrates all findings to confirm the diagnosis:

Parameter	Finding in This Patient	Score
Kayser-Fleischer rings: Present	Present	+2
Neurological symptoms: Severe	Wing-beating tremor + dystonia + dysarthria	+2
Ceruloplasmin: < 0.1 g/L	0.06 g/L	+2
Coombs-negative haemolytic anaemia: Present	DAT negative, Hb 9.5	+1
Liver copper: > 5× ULN	380 μg/g dry weight	+2
24-hour urine copper: >2× ULN	380 μg/day	+2
ATP7B mutations: Both chromosomes	Compound heterozygote	+4

Total Leipzig Score: 15 points

Score	Interpretation
> 4	Wilson disease confirmed
3	Further testing indicated
≤ 2	Wilson disease unlikely

Score 15 = Wilson Disease Definitively Confirmed

PART 6 — FINAL DIFFERENTIAL TABLE: RULE IN / RULE OUT

Diagnosis	Points In Favour	Points Against	Verdict
Wilson disease	KF rings on slit-lamp, wing-beating tremor, dystonia, dysarthria, drooling, hepatomegaly + cirrhosis, Coombs-negative haemolytic anaemia, age 19, consanguinity, sibling with liver disease, low ceruloplasmin, elevated urine copper, elevated hepatic copper >5× ULN, "face of giant panda" on MRI, ATP7B mutations, Azure lunulae, renal Fanconi syndrome, Leipzig score 15	None	CONFIRMED - PRIMARY DIAGNOSIS
Autoimmune Hepatitis	Young, liver disease, jaundice	No KF rings in AIH, no extrapyramidal signs, IgG not markedly elevated, ASMA/ANA negative	Ruled Out (may co-exist on biopsy - overlap)
Chronic Hepatitis B	Liver disease, young	No viral risk factors, HBsAg negative, no extrapyramidal signs	Ruled Out
Juvenile Huntington's disease	Psychiatric, movement disorder, young	Autosomal dominant (not AR), no liver disease, no KF rings, no copper abnormality	Ruled Out
Parkinson's disease	Tremor, rigidity, bradykinesia	Age 19 (extremely unusual), KF rings present, cerebellar signs, liver disease, elevated copper	Ruled Out
Haemochromatosis	Liver disease, young, AR, consanguinity	Normal/low ferritin, no iron overload, no extrapyramidal signs, no KF rings - copper elevated not iron	Ruled Out
Primary Sclerosing Cholangitis	Young, liver disease, jaundice	No IBD, MRCP would be normal, no extrapyramidal signs	Ruled Out
NAFLD/NASH	Liver disease	BMI low (18.5), no metabolic syndrome, no copper pathology explained	Ruled Out
Spinocerebellar ataxia	Cerebellar signs	Predominantly cerebellar, no liver disease, no KF rings, no copper pathology	Ruled Out
Drug-induced movement disorder	On escitalopram	Escitalopram rarely causes EPS; does not explain liver disease, KF rings, copper abnormalities	Ruled Out

PART 7 — FINAL DIAGNOSIS

Primary Diagnosis:

Wilson Disease (Hepatolenticular Degeneration) - Leipzig Score 15 ATP7B gene compound heterozygous mutation confirmed

Manifestations identified:

Neurological: Mixed extrapyramidal (wing-beating tremor, dystonia, rigidity, bradykinesia) + Cerebellar (dysmetria, ataxia) + Bulbar (dysarthria, dysphagia) + Cognitive (frontosubcortical)
Psychiatric: Personality change, depression, emotional lability (organic psychiatric disease)
Hepatic: Chronic active hepatitis progressing to cirrhosis, portal hypertension, ascites
Haematological: Coombs-negative haemolytic anaemia
Ophthalmic: Kayser-Fleischer rings + sunflower cataracts
Renal: Fanconi syndrome (proximal tubular dysfunction)
Musculoskeletal: Arthropathy (copper deposition in joints)

PART 8 — MANAGEMENT OUTLINE

(Based on Yamada's Textbook of Gastroenterology, Table 94.3 and Goldman-Cecil Medicine, 2022 AASLD Guidelines)

Issue	Management
Initial chelation (hepatic + neurological)	Trientine 1-2 g/day in 2-3 divided doses (preferred over penicillamine - better tolerated, less neurological worsening); or D-penicillamine 1-2 g/day with pyridoxine 25 mg/day
Zinc (adjunct/maintenance)	Zinc acetate 50 mg TDS - blocks intestinal copper absorption
Caution with penicillamine	20-50% of neurological patients worsen acutely on starting penicillamine; trientine preferred
Low-copper diet	Avoid shellfish, organ meats, mushrooms, chocolate, nuts; use distilled water if copper pipes present
Ascites	Spironolactone + furosemide; dietary sodium restriction
Haemolysis	Monitor Hb; treat underlying copper load
Neurological worsening monitoring	Neurological assessment monthly for first 6 months of treatment
Monitoring response	24-hour urine copper (initial: target 200-500 μg/day to confirm adequate chelation; later: <100 μg/day); liver function tests; serum non-ceruloplasmin copper
Liver transplantation	For fulminant hepatic failure with Wilson disease or end-stage cirrhosis unresponsive to medical therapy; transplantation corrects the metabolic defect
Psychiatric symptoms	Treat organically first (copper chelation); antipsychotics/antidepressants only if residual after adequate copper reduction
Sibling screening	All first-degree relatives must be screened: slit-lamp, ceruloplasmin, urine copper, ATP7B genotyping
Gene therapy	Under investigation (Harrison's, 22nd edition)
Lifelong therapy	Treatment is lifelong; discontinuation causes relapse and fulminant hepatic failure

DIAGNOSTIC REASONING PATHWAY (Summary)

19-year-old male, consanguineous parents
         ↓
Psychiatric symptoms (12 months) → Movement disorder (6 months) → Liver disease (3 months)
         ↓
Triad: Psychiatric + Extrapyramidal + Hepatic in a YOUNG patient
         ↓
IMMEDIATE SUSPICION: Wilson disease
         ↓
Slit-lamp: Kayser-Fleischer rings + Sunflower cataract → CONFIRMED
Azure lunulae + Coombs-negative haemolysis + Renal Fanconi syndrome
         ↓
Ceruloplasmin < 0.10 g/L + 24-h urine copper > 2× ULN + Liver copper > 5× ULN
         ↓
MRI Brain: "Face of the giant panda" sign → PATHOGNOMONIC
         ↓
ATP7B mutations on both chromosomes
         ↓
Leipzig Score: 15/15 → WILSON DISEASE CONFIRMED
         ↓
Treatment: Trientine + Zinc + Low-copper diet + Lifelong monitoring
         ↓
Screen all first-degree relatives

References:

Bradley and Daroff's Neurology in Clinical Practice - Chapter 96: Wilson Disease (Hepatolenticular Degeneration)
Goldman-Cecil Medicine - Chapter 395: Wilson Disease (Michael L. Schilsky)
Harrison's Principles of Internal Medicine, 22nd Edition (2025) - Chapter 427: Diagnosis and Molecular Features of Wilson's Disease
Yamada's Textbook of Gastroenterology, 7th Edition - Chapter 94: Leipzig Scoring System and Treatment
Robbins & Kumar Basic Pathology - Chapter 14: Wilson Disease Morphology and Pathogenesis
Robbins, Cotran & Kumar Pathologic Basis of Disease - Wilson Disease
Sleisenger and Fordtran's Gastrointestinal and Liver Disease - Chapters 76 and 95: Wilson Disease and Acute Liver Failure
Kanski's Clinical Ophthalmology, 10th Edition - Kayser-Fleischer Rings

This is a shared conversation. Sign in to Orris to start your own chat.